Core Insights - The life and health sector is entering a new phase of "deep integration and rapid development" driven by globalization and technological revolution, with advanced technologies like artificial intelligence and brain-computer interfaces expanding the pathways for innovative drug and therapy translation [1] Group 1: Forum Highlights - The fifth Guanghua Forum held at Fudan University focused on "leading the frontier, cross-border integration, and empowering transformation," aiming to build a high-end platform for thought exchange and resource connection [1] - Experts emphasized the importance of translating scientific research into practical applications, with a focus on addressing clinical problems and ensuring that innovations are applicable and beneficial to society [2] Group 2: Research and Innovation - The integration of artificial intelligence and synthetic biology is reshaping the research paradigm in life sciences, with a push towards making biomedical research a quantitative science through big data and AI [2] - Challenges in the translation of synthetic biology technologies into the health industry include the need for a regulatory science-based approval system and effective collaboration between innovation and industry chains [2] Group 3: Institutional Development - The Guanghua Life and Health Association has become a crucial hub linking academia, industry, and investment, with over 14 member units and a network of more than 6,000 alumni [3] - Future initiatives will focus on project result showcases and facilitating connections between early-stage innovation projects and industry [3] Group 4: Collaborative Achievements - A cooperation agreement was signed between the Macau Translational Medicine Center and Fudan University Pudong Hospital to establish a research institute focused on micro-nano sensing technology, microfluidics, and organ chips [4]